SCHEMBL17675348

SCHEMBL17675348

Cc1n[nH]c(C)c1-c1ccnn1C1CCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.40
PIK3CD O00329 7/20 0.38
CHEK1 O14757 1/20 0.38
AKT2 P31751 1/20 0.38
PKM P14618 2/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
ALOX15 P16050 1/20 0.38
KMT2A Q03164 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
BRD4 O60885 2/20 0.38
NR3C2 P08235 1/20 0.38
GAA P10253 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAPK1 P28482 1/20 0.36
HPGD P15428 1/20 0.35
BRD3 Q15059 1/20 0.35
DRD2 P14416 1/20 0.34
DRD4 P21917 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28848946 0.77 PIK3CD (0.38) PIK3CDPKMMEN1ALDH1A1MAPT
SCHEMBL30088763 0.77 BRD4 (0.40) PIK3CDPKMMEN1ALDH1A1MAPT
SCHEMBL30088695 0.76 PIK3CD (0.44) PIK3CDPKMMEN1ALDH1A1MAPT
SCHEMBL23923690 0.71 NR3C2 (0.43) PIK3CDPKMBRD4NR3C2
SCHEMBL30088715 0.70 BRD4 (0.44) PIK3CDBRD4
SCHEMBL18250762 0.69 SMN1; SMN2 (0.44) PIK3CDPKMMEN1ALDH1A1MAPT
SCHEMBL30088752 0.69 NR3C2 (0.42) PIK3CDPKMMEN1ALDH1A1MAPT
SCHEMBL30088753 0.69 ABCB1 (0.45) PIK3CDBRD4
SCHEMBL30088774 0.69 ABCB1 (0.45) PIK3CDBRD4
SCHEMBL12126299 0.68 SMN1; SMN2 (0.43) PIK3CDPKMMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12202826-B2 N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway REDX PHARMA PLC (GB) 2025-01-21 US disclosed
US-20230365549-A1 N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALING PATHWAY REDX PHARMA PLC (GB) 2023-11-16 US disclosed
US-11643408-B2 N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway REDX PHARMA PLC (GB) 2023-05-09 US disclosed
EP-3204378-B3 N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAY REDX PHARMA PLC (GB) 2022-05-25 EP disclosed
US-20210046076-A1 N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALING PATHWAY REDX PHARMA PLC (GB) 2021-02-18 US disclosed
US-10793560-B2 N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway REDX PHARMA PLC (GB) 2020-10-06 US disclosed
EP-3204378-B1 N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAY REDX PHARMA PLC (GB) 2019-07-10 EP disclosed
US-20180319788-A1 N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALING PATHWAY REDX PHARMA PLC (GB) 2018-11-08 US disclosed
US-20170275276-A1 N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALING PATHWAY REDX PHARMA PLC (GB) 2017-09-28 US disclosed
EP-3204378-A1 N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAY Redx Pharma PLC (GB) 2017-08-16 EP disclosed
WO-2016055786-A1 N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAY REDX PHARMA PLC (GB) 2016-04-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12202826-B2 N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway WNT1, WNT3, CTNNB1 MKNK1 653/4885PIK3CD 267/4885CHEK1 2572/4885
US-10793560-B2 N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway WNT1, WNT3, CTNNB1 MKNK1 688/4885PIK3CD 338/4885CHEK1 2900/4885
US-20230365549-A1 N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALING PATHWAY WNT1, WNT3, CTNNB1 MKNK1 653/4885PIK3CD 267/4885CHEK1 2572/4885
US-20180319788-A1 N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALING PATHWAY WNT1, WNT3, CTNNB1 MKNK1 688/4885PIK3CD 338/4885CHEK1 2900/4885
US-20170275276-A1 N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALING PATHWAY WNT1, WNT3, CTNNB1 MKNK1 688/4885PIK3CD 338/4885CHEK1 2900/4885
US-20210046076-A1 N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALING PATHWAY WNT1, WNT3, CTNNB1 MKNK1 653/4885PIK3CD 267/4885CHEK1 2572/4885
US-11643408-B2 N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway WNT1, WNT3, CTNNB1 MKNK1 653/4885PIK3CD 267/4885CHEK1 2572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.